small molecule

LARODOPA

LEVODOPA

Loss of exclusivityloss of exclusivity
CompanyHOFFMANN LA ROCHE INC

Drug detail

Brand nameLARODOPA
Active ingredientLEVODOPA
Strength100MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LARODOPA patent cliff — loss of exclusivity — | CliffBio